Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_assertion type Assertion NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_head.
- NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_assertion description "[Furthermore, immunohistochemical staining of ERalpha-positive primary breast cancers for p68 and p72 indicate that p72 expression is associated with an increased period of relapse-free and overall survival (P=0.006 and 0.016, respectively), as well as being inversely associated with Her2 expression (P=0.008).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_provenance.
- NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_assertion evidence source_evidence_literature NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_provenance.
- NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_assertion SIO_000772 19718048 NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_provenance.
- NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_assertion wasDerivedFrom befree-2016 NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_provenance.
- NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_assertion wasGeneratedBy ECO_0000203 NP760287.RAnNM9qlqdrB_6cIziLo6lczZB4-MiTHi8sVhGhKAxtHo130_provenance.